Posts

HairMax Density Hair Care System

Hair Loss & Growth Treatments

Global Hair Loss & Growth Treatments and Products Market Growth 2021-2026

According to this latest study, the 2021 growth of Hair Loss & Growth Treatments and Products will have significant change from the previous year.

By the most conservative estimates of global Hair Loss & Growth Treatments and Products market size (a most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3238 million in 2020.

Over the next five years, the Hair Loss & Growth Treatments and Products market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 4058.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hair Loss & Growth Treatments and Products market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Men

Women

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs

Ultrax Labs

Avalon Natural Products

Bayer

Pharma Medico

Kirkland Signature

Phyto Ales

Amplixin

Kerafiber

Phyto

Keranique

DS Healthcare

Kaminomoto

Softto

Bawang

Zhang Guang 101

Global Hair Loss & Growth Treatments and Products Market Growth 2021-2026

Source

Recent Posts

US Hair Transplant Procedure

HairMax Density Hair Care System

Hair Loss & Growth Treatments

Global Hair Loss & Growth Treatments and Products Market Growth 2021-2026

According to this latest study, the 2021 growth of Hair Loss & Growth Treatments and Products will have significant change from the previous year.

By the most conservative estimates of global Hair Loss & Growth Treatments and Products market size (a most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3238 million in 2020.

Over the next five years, the Hair Loss & Growth Treatments and Products market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 4058.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hair Loss & Growth Treatments and Products market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Men

Women

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs

Ultrax Labs

Avalon Natural Products

Bayer

Pharma Medico

Kirkland Signature

Phyto Ales

Amplixin

Kerafiber

Phyto

Keranique

DS Healthcare

Kaminomoto

Softto

Bawang

Zhang Guang 101

Global Hair Loss & Growth Treatments and Products Market Growth 2021-2026

Source

Recent Posts

US Hair Transplant Procedure

biomarker linked to hair loss

biomarker linked to hair loss

Novel biomarker linked to hair loss can determine COVID severity in men

Researchers have discovered a novel biomarker to identify male COVID-19 patients most at risk for ICU admission. The findings presented today at EADV’s 2021 Spring Symposium, suggest that men with genetic characteristics (phenotypes) sensitive to the male sex hormone androgen, are more likely to experience severe COVID-19 disease.

Researchers were driven to study the association between the androgen receptor (AR) gene and COVID-19, after observing the disproportionate number of men hospitalised with COVID-19 presenting with androgenetic alopecia (a common form of hair-loss) compared to the expected number in a similar age-matched population (79% vs. 31-53%).

Androgenetic alopecia is known to be controlled by variations in the AR gene, which affects how sensitive the body is to androgens (hormones such as testosterone). In addition, an enzyme implicated in COVID-19 infection (TMPRSS2) is regulated by an androgen response element – meaning that it too may be affected by variations in the AR gene. As the polyglutamine repeat (CAG repeat) region located in the AR gene is associated with both androgen sensitivity and androgenetic alopecia; this research sought to identify the connection between CAG repeat region length and predisposition to increased COVID disease severity.

A prospective study of 65 hospitalised COVID-19 positive men measured the AR CAG repeat length of each man. Researchers found that male covid patients with a CAG repeat below 22 nucleotides (CAG<22) were significantly less likely to be admitted into ICU than patients with a CAG count over or equal to 22 nucleotides (CAG?22; p=0.05).

Dr. Andy Goren, Chief Medical Officer, Applied Biology, Inc., Irvine, California, USA, explains: “Our data show that longer AR CAG scores are associated with more severe COVID?19 disease and indicate that AR CAG repeat length could be used as a biomarker to help identify male COVID? 19 patients most at risk for ICU admissions.”

He continues, “The identification of a biomarker connected with the androgen receptor is another piece of evidence highlighting the important role of androgens in COVID-19 disease severity.”

Further research conducted by Dr Andy Goren and his team, reported at the EADV Spring Symposium, explores a promising new therapy for COVID-19 using a novel androgen receptor antagonist to regulate TMPRSS2 expression and possibly treat COVID-19 patients. The results of this study were submitted for publication in a peer-reviewed journal.

“This research demonstrates the scientific value of dermatology by offering key insights into the role of genetics and its link to COVID disease. It is an excellent example of some of the pioneering abstracts being showcased at The EADV Spring Symposium this year,” says Prof. Lidia Rudnicka, EADV Board Member and Professor at the Medical University of Warsaw.

Novel biomarker linked to hair loss can determine COVID severity in men

Source

Recent Posts

US Hair Transplant Procedure

Dandruff Treatment Market

Dandruff Treatment Market

Global Dandruff Treatment Market Research Report 2021-2025

These dandruff shampoos encourage the healing of scales on your scalp. In the context of the China-US trade war and the COVID-19 epidemic, it will have a big influence on this market. Dandruff Treatment Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Dandruff Treatment market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Dandruff Treatment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc.

In the end, the report introduced a new project SWOT analysis, investment feasibility analysis, and investment return analysis. The major players profiled in this report include Unilever L’ORÉAL Arcadia Consumer Healthcare Vyome Therapeutics ……

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into- General Type ……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dandruff Treatment for each application, including- Health ……
Table of Contents

Part I Dandruff Treatment Industry Overview

Chapter One Dandruff Treatment Industry Overview

1.1 Dandruff Treatment Definition
1.2 Dandruff Treatment Classification Analysis
1.2.1 Dandruff Treatment Main Classification Analysis
1.2.2 Dandruff Treatment Main Classification Share Analysis
1.3 Dandruff Treatment Application Analysis
1.3.1 Dandruff Treatment Main Application Analysis
1.3.2 Dandruff Treatment Main Application Share Analysis
1.4 Dandruff Treatment Industry Chain Structure Analysis
1.5 Dandruff Treatment Industry Development Overview
1.5.1 Dandruff Treatment Product History Development Overview
1.5.1 Dandruff Treatment Product Market Development Overview
1.6 Dandruff Treatment Global Market Comparison Analysis
1.6.1 Dandruff Treatment Global Import Market Analysis
1.6.2 Dandruff Treatment Global Export Market Analysis
1.6.3 Dandruff Treatment Global Main Region Market Analysis
1.6.4 Dandruff Treatment Global Market Comparison Analysis
1.6.5 Dandruff Treatment Global Market Development Trend Analysis

Chapter Two Dandruff Treatment Up and Down Stream Industry Analysis

2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Dandruff Treatment Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Dandruff Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Dandruff Treatment Market Analysis

3.1 Asia Dandruff Treatment Product Development History
3.2 Asia Dandruff Treatment Competitive Landscape Analysis
3.3 Asia Dandruff Treatment Market Development Trend

Chapter Four 2016-2021 Asia Dandruff Treatment Productions Supply Sales Demand Market Status and Forecast

4.1 2016-2021 Dandruff Treatment Production Overview
4.2 2016-2021 Dandruff Treatment Production Market Share Analysis
4.3 2016-2021 Dandruff Treatment Demand Overview
4.4 2016-2021 Dandruff Treatment Supply Demand and Shortage
4.5 2016-2021 Dandruff Treatment Import Export Consumption
4.6 2016-2021 Dandruff Treatment Cost Price Production Value Gross Margin

Chapter Five Asia Dandruff Treatment Key Manufacturers Analysis

5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Dandruff Treatment Industry Development Trend

6.1 2021-2025 Dandruff Treatment Production Overview
6.2 2021-2025 Dandruff Treatment Production Market Share Analysis
6.3 2021-2025 Dandruff Treatment Demand Overview
6.4 2021-2025 Dandruff Treatment Supply Demand and Shortage
6.5 2021-2025 Dandruff Treatment Import Export Consumption
6.6 2021-2025 Dandruff Treatment Cost Price Production Value Gross Margin

Part III North American Dandruff Treatment Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Dandruff Treatment Market Analysis

7.1 North American Dandruff Treatment Product Development History
7.2 North American Dandruff Treatment Competitive Landscape Analysis
7.3 North American Dandruff Treatment Market Development Trend

Chapter Eight 2016-2021 North American Dandruff Treatment Productions Supply Sales Demand Market Status and Forecast

8.1 2016-2021 Dandruff Treatment Production Overview
8.2 2016-2021 Dandruff Treatment Production Market Share Analysis
8.3 2016-2021 Dandruff Treatment Demand Overview
8.4 2016-2021 Dandruff Treatment Supply Demand and Shortage
8.5 2016-2021 Dandruff Treatment Import Export Consumption
8.6 2016-2021 Dandruff Treatment Cost Price Production Value Gross Margin

Chapter Nine North American Dandruff Treatment Key Manufacturers Analysis

9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Dandruff Treatment Industry Development Trend

10.1 2021-2025 Dandruff Treatment Production Overview
10.2 2021-2025 Dandruff Treatment Production Market Share Analysis
10.3 2021-2025 Dandruff Treatment Demand Overview
10.4 2021-2025 Dandruff Treatment Supply Demand and Shortage
10.5 2021-2025 Dandruff Treatment Import Export Consumption
10.6 2021-2025 Dandruff Treatment Cost Price Production Value Gross Margin

Part IV Europe Dandruff Treatment Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Dandruff Treatment Market Analysis

11.1 Europe Dandruff Treatment Product Development History
11.2 Europe Dandruff Treatment Competitive Landscape Analysis
11.3 Europe Dandruff Treatment Market Development Trend

Chapter Twelve 2016-2021 Europe Dandruff Treatment Productions Supply Sales Demand Market Status and Forecast

12.1 2016-2021 Dandruff Treatment Production Overview
12.2 2016-2021 Dandruff Treatment Production Market Share Analysis
12.3 2016-2021 Dandruff Treatment Demand Overview
12.4 2016-2021 Dandruff Treatment Supply Demand and Shortage
12.5 2016-2021 Dandruff Treatment Import Export Consumption
12.6 2016-2021 Dandruff Treatment Cost Price Production Value Gross Margin

Chapter Thirteen Europe Dandruff Treatment Key Manufacturers Analysis

13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Dandruff Treatment Industry Development Trend
14.1 2021-2025 Dandruff Treatment Production Overview
14.2 2021-2025 Dandruff Treatment Production Market Share Analysis
14.3 2021-2025 Dandruff Treatment Demand Overview
14.4 2021-2025 Dandruff Treatment Supply Demand and Shortage
14.5 2021-2025 Dandruff Treatment Import Export Consumption
14.6 2021-2025 Dandruff Treatment Cost Price Production Value Gross Margin

Part V Dandruff Treatment Marketing Channels and Investment Feasibility

Chapter Fifteen Dandruff Treatment Marketing Channels Development Proposals Analysis
15.1 Dandruff Treatment Marketing Channels Status
15.2 Dandruff Treatment Marketing Channels Characteristic
15.3 Dandruff Treatment Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis

16.1 China Macroeconomic Environment Analysis*
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Dandruff Treatment New Project Investment Feasibility Analysis

17.1 Dandruff Treatment Market Analysis
17.2 Dandruff Treatment Project SWOT Analysis
17.3 Dandruff Treatment New Project Investment Feasibility Analysis

Part VI Global Dandruff Treatment Industry Conclusions

Chapter Eighteen 2016-2021 Global Dandruff Treatment Productions Supply Sales Demand Market Status and Forecast

18.1 2016-2021 Dandruff Treatment Production Overview
18.2 2016-2021 Dandruff Treatment Production Market Share Analysis
18.3 2016-2021 Dandruff Treatment Demand Overview
18.4 2016-2021 Dandruff Treatment Supply Demand and Shortage
18.5 2016-2021 Dandruff Treatment Import Export Consumption
18.6 2016-2021 Dandruff Treatment Cost Price Production Value Gross Margin

Chapter Nineteen Global Dandruff Treatment Industry Development Trend

19.1 2021-2025 Dandruff Treatment Production Overview
19.2 2021-2025 Dandruff Treatment Production Market Share Analysis
19.3 2021-2025 Dandruff Treatment Demand Overview
19.4 2021-2025 Dandruff Treatment Supply Demand and Shortage
19.5 2021-2025 Dandruff Treatment Import Export Consumption
19.6 2021-2025 Dandruff Treatment Cost Price Production Value Gross Margin

Chapter Twenty Global Dandruff Treatment Industry Research Conclusions

Global Dandruff Treatment Market Research Report 2021-2025

Source

Recent Posts

Men and Women Hair Loss Market

Men and Women Hair Loss Market

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Men and Women Hair Loss market report provide a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Men and Women Hair Loss size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Men and Women Hair Loss market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

The men and Women Hair Loss market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Market segment by Application can be divided into

Men

Women

Market segment by players, this report covers

Procter & Gamble

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer Inc.

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs Ltd.

Ultrax Labs

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of the Middle East & Africa)

The content of the study subjects includes a total of 12 chapters:

Chapter 1, describe Men and Women Hair Loss product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, profile the top players of Men and Women Hair Loss, with revenue, gross margin and global market share of Men and Women Hair Loss from 2019 to 2021.

Chapter 3, the Men and Women Hair Loss competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021. and Men and Women Hair Loss market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, describe Men and Women Hair Loss research findings and conclusion, appendix and data source.

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Source

Recent Posts

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

The OTC Hair Loss Treatments is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period.

The research provides insights for the global OTC Hair Loss Treatments market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the OTC Hair Loss Treatments industry.

For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global OTC Hair Loss Treatments Market Segmentations:

By Players:

  • Merck
  • J&J
  • Taisho Pharma
  • Costco Wholesale
  • Wal-Mart
  • Bayer
  • Zhejiang Wansheng Pharma
  • Sichuan Medco Huakang Pharma
  • Zhendong Anter
  • DrFormulas
  • Renata
  • DrRPFLEGER
  • DS Healthcare Group

By Types:

  • Minoxidil
  • Procapil
  • Other

By End-User:

  • Male
  • Female

By Regions:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Italy
  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
  • Spain
  • Belgium
  • Poland
  • Russia
  • Turkey
  • Others

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia and New Zealand
  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
  • Brazil
  • Nigeria
  • South Africa
  • Argentina
  • Others

Global OTC Hair Loss Treatments Market

Source

Recent Posts

Scalp Microneedling Market

Scalp Microneedling Market

Global Scalp Microneedling Market Report 2020

The Scalp Microneedling market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period.

The global Scalp Microneedling market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Scalp Microneedling market. The report focuses on well-known providers in the global Scalp Microneedling industry, market segments, competition, and the macro environment._x000D_
_x000D_

Under COVID-19 Outbreak, how the Scalp Microneedling Industry will develop is also analyzed in detail in Chapter 1.7 of the report._x000D_

In Chapter 2.4, we analyzed industry trends in the context of COVID-19._x000D_

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets._x000D_

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries._x000D_

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out._x000D_
_x000D_

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players._x000D_
_x000D_

Key players in the global Scalp Microneedling market covered in Chapter 4:_x000D_

zcalp
Lotus
Yonghe Hair Transplant
_x000D_

In Chapter 11 and 13.3, on the basis of types, the Scalp Microneedling market from 2015 to 2026 is primarily split into:_x000D_
Under 0.25 mm
25mm-0.3mm
75mm-1.0mm
1.0mm-1.5mm
Above 1.5mm
_x000D_

In Chapter 12 and 13.4, on the basis of applications, the Scalp Microneedling market from 2015 to 2026 covers:_x000D_
Hair Transplant
Boost Hair
Others
_x000D_

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:_x000D_

North America (Covered in Chapter 6 and 13)_x000D_
United States_x000D_
Canada_x000D_
Mexico_x000D_
Europe (Covered in Chapter 7 and 13)_x000D_
Germany_x000D_
UK_x000D_
France_x000D_
Italy_x000D_
Spain_x000D_
Russia_x000D_
Others_x000D_
Asia-Pacific (Covered in Chapter 8 and 13)_x000D_
China_x000D_
Japan_x000D_
South Korea_x000D_
Australia_x000D_
India_x000D_
Southeast Asia_x000D_
Others_x000D_
Middle East and Africa (Covered in Chapter 9 and 13)_x000D_
Saudi Arabia_x000D_
UAE_x000D_
Egypt_x000D_
Nigeria_x000D_
South Africa_x000D_
Others_x000D_
South America (Covered in Chapter 10 and 13)_x000D_
Brazil_x000D_
Argentina_x000D_
Columbia_x000D_
Chile_x000D_
Others_x000D_
_x000D_

Years considered for this report:_x000D_

Historical Years: 2015-2019_x000D_
Base Year: 2019_x000D_
Estimated Year: 2020_x000D_
Forecast Period: 2020-2026

Global Scalp Microneedling Market Report 2020

Source

Recent Posts

Alopecia Market

Alopecia Market

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Market Synopsis

The global alopecia market size was valued at USD 2,650.8 Million in 2019 and is forecasted to reach USD 5,250.8 Million by 2027 at a CAGR of 8.9%. The alopecia market is projected to experience rapid growth attributed to the prevalence of various disease types comprising alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, and cicatricle alopecia. Factors such as increasing incidence of chronic diseases, rising cases of Polycystic Ovary Syndrome (PCOS), rise in the level of disposable income, and advancements in medical technology for delivering enhanced treatment.

Diseases such as thyroid disorders, cancer, lupus, muscular dystrophy, heavy metal poisoning, pituitary gland disease, sarcoidosis, syphilis in last-stage, and continuing chronic diseases may lead to alopecia. It has been found that about 65.0% of people receiving chemotherapy are likely to suffer from chemotherapy-induced hair loss. In comparison, the deployment of cancer treatment with molecularly targeted agents has been linked with hair loss rates up to a maximum of 60.0%.

Additionally, advancements in technology and usage of emerging therapeutics such as stem cells, cellular pathways, growth factors, and robotic hair transplant, for alopecia, provide ample opportunities to boost the market growth.

However, a low level of awareness about the condition may hamper the market’s growth in the forecast period.Type Insights

By type, alopecia areata accounted for the largest market share of over 31.0% of the alopecia market in 2019

Alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence. In the US, it affects approximately 6.8 million individuals. In a large number of cases, this condition causes hairs to fall-out in various amounts ranging from small patches to severe hair loss. Occasionally, it may result in total hair loss on the scalp and the whole body in extreme conditions. The disease affects individuals regardless of their gender and age.

The disease’s likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population.

Application Insights

By application, men accounted for the largest market share 65.0% of the alopecia market in 2019

Alopecia/hair-loss in men caused several factors, including smoking, consumption of alcoholic beverages, stress, drug abuse, and genetics, among other factors. Male pattern baldness or androgenic alopecia, a hereditary cause of hair loss, may be triggered at any point in a man’s life, including adolescence.

As per a study conducted by the US National Library of Medicine (NLM), over 50.0% of the global male population beyond the age of 50 will experience male pattern baldness to a certain extent.

End-Users Insights

By end-users, dermatology clinics is likely to grow at the fastest rate of 9.5% in the forecast period

Dermatology clinics expert medical professionals trained for diagnosing conditions including skin (scalp) and hair. Dermatologists help find the root cause of hair problems and successfully cure hair-loss in several cases. The high market share of dermatology clinics is due to the rising number of surgeries associated with hair transplantation and restoration and the extensive usage of prescription drugs.

Dermatology clinics possess the expertise to prevent thinning of hairs and boost hair growth. In the US, the FDA has sanctioned minoxidil for the treatment of hair loss and is the only approved hair re-growth product. A dermatologist can incorporate minoxidil with other treatment methods to cure hair loss.

Regional Insights

By region, North America accounted for the largest market share of over 36.0% of the alopecia market in 2019

The North American region’s market dominance is due to the high alopecia incidence, advanced healthcare infrastructure, high per-capita income, and accessibility to innovative treatment options for hair loss. Increased investment in R&D and a rising number of patent approvals in the region are also causatives of market growth.

The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period attributed to increasing incidence of chronic disorders, growing awareness among the population, especially in people of the young generation, and a rise in the level of disposable income.

Major Companies and Market Share Analysis

The leading players in the alopecia market are equipped with enhanced production facilities and are involved in various R&D activities. A few leading players in the alopecia market include:

  • Johnson & Johnson Services Inc.
  • Cirrus Hair Centers
  • Cipla Inc.
  • Follica Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Convert Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Aclaris Therapeutics Inc.
  • HCell Inc.

In January 2020, Revian made an announcement about the receiving of a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues such as including hair.

Scope Of Research

PARAMETERS
DETAILS

The market size value in 2019
USD 2,650.8 million

CAGR (2020 – 2027)
8.9%

The revenue forecast in 2027
USD 5,250.8 million

Base year for estimation
2020

Historical data
2017-2019

Forecast period
2021-2028

Quantitative units
Revenue in USD Billion, and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, application, end-users, Region

Regional scope

North America; Europe; Asia Pacific; Central & South America; MEA

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey

Key companies profiled

Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc.

Customization scope

10 hrs of free customization and expert consultation

Segments Covered in the report

 

This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2027. The scope of the report can be defined as:

For the purpose of this report, Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027) 
    • Alopecia Areata
    • Androgenetic Alopecia
    • Alopecia Totalis
    • Traction Alopecia
    • Cicatricle Alopecia
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027) 
    • Male
    • Female
  • End-Users Outlook (Revenue, USD Billion; 2017-2027) 
    • Dermatology Clinics
    • Homecare Settings
    • Others
  • Distribution Channel Outlook (Revenue, USD Billion; 2017-2027) 
    • Prescription
    • OTC (Over-the-Counter)
  • Regional Outlook (Revenue, USD Billion; 2017-2027) 
    • North America

      1. U.S.
      2. Canada
      3. Mexico
    • Europe

      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific

      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America

      1. Brazil
      2. Rest of LATAM
    • MEA

      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Alopecia Market By Type, By Application, By End-Users, By Distribution Channel, Forecasts to 2027

Source

Recent Posts

Ziering Medical Center Opens in Greenwich

Ziering Medical Center Opens in Greenwich

Ziering Medical Center Opens in Greenwich

Dr. Craig Ziering announces the opening of his newest clinic in Greenwich, Connecticut with lead surgeon, Rae Lynne Kinler, M.D. Dr. Ziering will serve as Medical Director for the location, the fifth in the group.

Dr. Kinler, the first physician in her family, is one of the few female hair transplant specialists in the field and a top tier aesthetic surgeon specializing in a range of hair restoration techniques and treatments. Having successfully completed a year-long fellowship in Hair Restoration Surgery with Dr. Ziering, she was his top pick to join the highly respected Ziering Medical team in the fall of 2015 as a full-time hair transplant surgeon in Los Angeles. She has participated in research and development of Restoration Robotics with Dr. Ziering and has been invited to lecture on the topic at industry conferences.

According to Dr. Ziering, “I am so proud to have Dr. Kinler introduce the Ziering brand of treatments to the greater Greenwich community. Our advanced protocols and her exceptional surgical skills will elevate the category of hair restoration to local residents.”

Dr. Ziering is a pioneer in hair transplantation leadership, technology and education, who established his renowned Ziering Medical Group and brand in 2003 offering highly sought after surgical procedures, non-invasive hair loss treatments, advanced technologies, home care treatments, topicals and supplements.

“Greenwich was the ideal community for the next phase of our expansion,” said Anthony Castore, CEO of Ziering Medical. “This second east coast location gives us a broader-base to serve our clientele locally with integrated treatment and regular ongoing follow-up as we continue to grow the Ziering brand on a national scale.”

Ziering Medical currently serves a discerning global patient population, including high-profile personalities and public figures.

According to Dr. Kinler, “To be the best you have to be trained by the best and the experience with Dr. Ziering enabled me to be highly proficient in the latest in all surgical hair restoration procedures for men and women like Microscopically Dissected Elliptical Excision (MDEE) and particularly Follicular Unit Excision and Extraction (FUE).” A marathoner happy to be on the East Coast where she will continue to compete in IRONMAN and the NYC Marathon, she added, “I want to eliminate the stigma from hair restoration and hair transplantation procedures, especially for those with genetic predispositions. We can intervene early, manage the condition and ensure the best, most natural outcome for permanent, undetectable results for our patients.”

Dr. Kinler and her team are situated in their new office consisting of three state-of-the-art exam and surgical rooms in 2513 square feet of space located at 75 Holly Hill Lane, Suite 302, Greenwich, Connecticut 06830. Fully Covid-19 compliant, Ziering Medical of Greenwich is taking individual patients with clearance following all CDC protocols and provisions to keep patients and staffing safe and healthy. Ziering Medical Greenwich will offer all their signature services for male and female hair loss, including hairline restoration, beard and eyebrow hair transplants, truly customized hair restoration treatment plans for men, women transgender and African American patients, as well as minimally-invasive office treatments. Dr. Kinler is available for both virtual and in-person consultations. Additionally, she is available for public speaking engagements for local organizations. For more information visit Ziering Medical.

About Ziering Medical:

Founded in 2003 by Dr. Craig Ziering, a global leader in hair restoration, Ziering Medical is a multi-dimensional and fully comprehensive hair restoration practice combining state-of-the-art hair transplant procedures and hair regeneration therapies with highly personalized treatment programs to manage the progressive nature of hair loss. Dr. Ziering serves as Medical Director to four locations in Beverly Hills and Newport Beach, CA, Las Vegas, NV, Greenwich, CT, and a newly renovated flagship surgery center in New York City.

Ziering Medical offers services for male and female pattern baldness as well as expertise in African American hair, transgender hairline modification, beard and eyebrow restoration, using many techniques pioneered by Dr. Ziering. Understanding each patient’s unique hair restoration journey, Microscopically Dissected Elliptical Excision (MDEE) and Follicular Unit Excision and Extraction (FUE) are performed by Ziering surgeons, allowing for truly customized, personal treatment plans.

Taking a distinctive lifestyle approach, Ziering Medical provides a full array of non-surgical treatments and at-home care, including the Ziering Laser Cap, ZMin and ZFin, specially formulated topical minoxidil and finasteride, respectively. Stem cell scalp injection treatments with Amnio Z and Exosomes and lasers are all designed to meet the long term strategies and patient population needs. The first branded product line, a specialty hair loss shampoo and conditioner, formulated by Dr. Ziering, called Follicle Cleanse and Follicle Sustenance, will be available in early 2021.

Ziering Medical Center Opens in Greenwich

Source

Recent Posts

COVID Vaccine Can Also Help With Hair Loss

COVID Vaccine Can Also Help With Hair Loss

Technology Used in COVID Vaccine Can Also Help With Hair Loss

A key piece of technology used to create the Pfizer and Moderna COVID vaccines is also found in hi-tech injection therapy to battle hair loss for men and women. World-renowned hair restoration surgeon, Dr. Sara Wasserbauer, has incorporated exosome hair loss therapy into her armamentarium of treatments for her patients. Exosome injection therapy is a relatively non-invasive, in-office treatment that has shown early promise to slow down hair loss and, possibly even promote impressive new hair growth within just a few months.

“Exosome hair therapy is a promising new therapy option for many hair loss patients who have either tried about other every kind of treatment or who are looking for a non-pharmaceutical or non-surgical solution for their hair loss,” explains Dr. Wasserbauer, a Diplomate of the American Board of Hair Restoration Surgery and Fellow of the International Society of Hair Restoration Surgery. “This is a simple and safe injection therapy utilizing exosomes that carry the same messenger RNA used in the COVID vaccine with one major difference; instead of being used to fight a potentially deadly virus, the mRNA is used to stimulate new hair growth.”

WHAT ARE EXOSOMES?

  • Tiny nanoparticles discovered by scientists 35 five years ago
  • Do not contain DNA
  • Used for intercellular signalling
  • Contain messenger RNA (mRNA) and microRNA (miRNA) that execute cell-to-cell communication

Exosomes contain various growth factors. They are collected from stem cells in a process that is FDA registered and inspected. “It is important to note, exosome therapy is not stem cell therapy, and there is no approved ‘stem cell therapy for hair loss,” explains Dr. Wasserbauer. “Exosomes are extracellular vesicles, like tiny balloons, that are released from stem cells. The vesicles trigger signaling pathways for growth and healing, like for repairing a broken bone or promoting hair growth.”

A recent study by researchers at North Carolina State University supports how these kinds of messenger cells could trigger hair regeneration. The scientists found hair follicles do not disappear when someone starts balding. Instead, the follicles shrink or atrophy and become inactive. If the cells around the hair follicles could be replenished, those smaller follicles might recover and grow thicker hair shafts.

The exosome hair therapy process is so simple that Dr. Wasserbauer and her team can do the treatment in one of her exam rooms in her office. The doctor injects the exosomes into the fatty layer of the scalp that surrounds hair to stimulate the cells around hair follicles. “In some cases, we even add microdermabrasion to create small micro-wounds to help stimulate the exosomes,” says Dr. Wasserbauer. “This treatment and other injection therapies utilizing PRP (Platelet Rich Plasma) have shown impressively quick hair growth in some cases (click for example), and in many other cases, the growth continues for up to a year or more.”

Dr. Wasserbauer consults patients at multiple locations in Northern California. In addition to exosome hair therapy, she conducts a variety of other hair restoration procedures, including follicular unit hair transplantation (FUT or FUE), eyebrow and eyelash hair transplantation, scalp micro-pigmentation and low level light therapy. She is available for phone and virtual interviews to discuss any or all treatments.

About Dr. Wasserbauer, M.D., A.B.H.R.S., F.I.S.H.R.S.

Dr. Sara Wasserbauer is one of our nation’s leading hair restoration experts. In addition to her practice at three San Francisco offices, she currently serves as immediate Past-President of the Board of Directors for the American Board of Hair Restoration Surgeons. She also writes a monthly feature article for the ISHRS Hair Transplant Forum International and is a frequent media source on hair loss and related treatments. For more information, visit http://www.californiahairsurgeon.com

Technology Used in COVID Vaccine Can Also Help With Hair Loss

Source

Recent Posts

Hair Loss Treatment Industry Market

2020-2025 Global Hair Loss Treatment Market

2020-2025 Global Hair Loss Treatment Market Report

Hair loss refers to the phenomenon of hair loss. The hair that is normally shed is the hair that is in the period of retreat and rest. Since the hair entering the degenerative period and the newly entering the growing period is constantly in dynamic balance, the normal amount of hair can be maintained.

This report elaborates the market size, market characteristics, and market growth of the Hair Loss Treatment industry, and breaks down according to the type, application, and consumption area of Hair Loss Treatment. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hair Loss Treatment in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Hair Loss Treatment market covered in Chapter 13:

Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Shiseido Co., Ltd.
Johnson & Johnson, Inc.
Dr. Reddy’s Laboratories Ltd.
The Himalaya Drug Company
Taisho Pharmaceutical Holdings Co., Ltd
Zhangguang 101 Science & Technology Co., Ltd.
Cipla Ltd.
Johnson & Johnson, Inc.
Cellmid Ltd.

In Chapter 6, on the basis of types, the Hair Loss Treatment market from 2015 to 2025 is primarily split into:

Topical Drugs
Oral Drugs
Injectable Drugs
Hair Transplant Services
Low-level Laser Therapy

In Chapter 7, on the basis of applications, the Hair Loss Treatment market from 2015 to 2025 covers:

Hospitals
Dermatologic and Trichology Clinics
Home Care Settings
Aesthetic Clinics

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:

United States

Europe

China

Japan

India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)

United States

Canada

Mexico

Europe (Covered in Chapter 9)

Germany

UK

France

Italy

Spain

Others

Asia-Pacific (Covered in Chapter 10)

China

Japan

India

South Korea

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 11)

Saudi Arabia

UAE

South Africa

Others

South America (Covered in Chapter 12)

Brazil

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

2020-2025 Global Hair Loss Treatment Market Report

Source

Recent Posts